Arrowstreet Capital’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.3M Buy
+2,040,051
New +$13.6M 0.01% 913
2025
Q4
Sell
-135,496
Closed -$1.05M 2022
2025
Q3
$1.05M Buy
+135,496
New +$1.06M ﹤0.01% 1595
2023
Q1
Sell
-1,100,167
Closed -$26M 1522
2022
Q4
$26M Buy
1,100,167
+1,089,170
+9,904% +$29.4M 0.04% 331
2022
Q3
$279K Buy
+10,997
New +$386K ﹤0.01% 1172
2021
Q1
Sell
-1,746,745
Closed -$349M 2527
2020
Q4
$349M Buy
1,746,745
+644,851
+59% +$131M 0.49% 33
2020
Q3
$242M Buy
1,101,894
+57,720
+6% +$12.2M 0.38% 37
2020
Q2
$199M Buy
1,044,174
+755,308
+261% +$132M 0.37% 44
2020
Q1
$44.8M Buy
288,866
+98,377
+52% +$11.4M 0.13% 158
2019
Q4
$15.9M Buy
+190,489
New +$14.5M 0.04% 460

Other funds holding TDOC

Arrowstreet Capital's TDOC Position: Q2 2026 in Review

Arrowstreet Capital opened a new position in Teladoc Health (TDOC) in Q2 2026: 2,040,051 shares worth $17.3M. The stake represents 0.01% of the portfolio and ranks #913 among its holdings. This is a return to the name: Arrowstreet Capital previously reported a position in TDOC as recently as Q3 2025.

Arrowstreet Capital first reported a position in TDOC in Q4 2019 and has held it in 9 quarters since. The position peaked at $349M in Q4 2020. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Arrowstreet Capital held 2,040,051 shares of Teladoc Health worth $17.3M as of Q2 2026.
  • Teladoc Health was a new Arrowstreet Capital position in Q2 2026.
  • Teladoc Health made up 0.01% of Arrowstreet Capital's portfolio in Q2 2026, its #913 holding.
  • Arrowstreet Capital first reported a position in Teladoc Health in Q4 2019 and has held it in 9 quarters since.
  • Arrowstreet Capital's Teladoc Health position peaked at $349M in Q4 2020.
  • 347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.